Behzad Aghazadeh
InvestorManaging Partner & Portfolio Manager at Avoro Capital Advisors
FoundedScribe Therapeutics
About
Managing Partner and Portfolio Manager of Avoro Capital with over 25 years in the biopharmaceutical industry across research, consulting, investing and board leadership. He holds a physics master's from Ludwig-Maximilians-University and a PhD in Biochemistry & Biophysics from Cornell, and served as Executive Chairman of Immunomedics until its $21B acquisition by Gilead in 2020.
Colleagues at Avoro Capital Advisors
Andy Washkowitz
Director at Avoro Capital Advisors
Billy Smith
Associate at Avoro Capital Advisors
Bryan Phillips
Deputy Chief Compliance Officer at Avoro Capital Advisors
Corie Hansen
Office Manager / Executive Assistant at Avoro Capital Advisors
David Xiang
Associate at Avoro Capital Advisors
Diane Chien
Hedge Fund Controller at Avoro Capital Advisors
Jenna Glatzer
Associate - Avoro Ventures at Avoro Capital Advisors
Jenna McElhinney
Manager, Investor Relations & Marketing at Avoro Capital Advisors